Anti-stromal nanotherapeutics for hepatocellular carcinoma DOI
Zhuo Yu, Leaf Huang, Jianfeng Guo

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 367, P. 500 - 514

Published: Feb. 3, 2024

Language: Английский

New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication DOI Creative Commons
Sha Qin,

Bin Xie,

Qingyi Wang

et al.

MedComm, Journal Year: 2024, Volume and Issue: 5(6)

Published: May 23, 2024

Abstract Cancer is one of the leading causes death worldwide, and more effective ways attacking cancer are being sought. immunotherapy a new therapeutic method after surgery, radiotherapy, chemotherapy, targeted therapy. aims to kill tumor cells by stimulating or rebuilding body's immune system, with specific efficiency high safety. However, only few patients respond due complex variable characters escape, behavior regulatory mechanisms need be deeply explored from dimensions. Epigenetic modifications, metabolic modulation, cell‐to‐cell communication key factors in cell adaptation response microenvironment. They collectively determine state function through modulating gene expression, changing energy nutrient demands. In addition, engage networks other components, which mediated exosomes, cytokines, chemokines, pivotal shaping progression response. Understanding interactions combined effects such multidimensions modulation important for revealing failure developing targets strategies.

Language: Английский

Citations

13

Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma DOI Creative Commons
Hao Zhang,

Ying Hong,

Tingting Wu

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: June 10, 2024

Glioblastoma (GBM) is a highly malignant, invasive, and poorly prognosed brain tumor. Unfortunately, active comprehensive treatment does not significantly prolong patient survival. With the deepening of research, it has been found that gut microbiota plays certain role in GBM, can directly or indirectly affect efficacy immune checkpoint inhibitors (ICIs) various ways. (1) The metabolites produced by host’s homeostasis, these function distribution cells, promote inhibit inflammatory responses, phenotype, angiogenesis, response, cell infiltration GBM thereby affecting effectiveness ICIs. (2) Some members may reverse T inhibition, increase anti-tumor activity, ultimately improve ICIs targeting specific immunosuppressive cytokines. (3) participate metabolic process drugs, which degrade, transform, produce metabolites, effective concentration bioavailability drugs. Optimizing structure help (4) also regulate status through axis communication, progression therapeutic response to (5) Given importance for ICI therapy, researchers have begun exploring use fecal transplantation (FMT) transplant healthy optimized patients, order their enhance therapy. Preliminary studies suggest FMT therapy some patients. In summary, crucial regulating with deeper understanding relationship between tumor immunity, expected develop more precise personalized strategies prognosis.

Language: Английский

Citations

12

Bio-gel nanoarchitectonics in tissue engineering DOI Creative Commons
Jingwen Song,

Wenyan Lyu,

Kohsaku Kawakami

et al.

Nanoscale, Journal Year: 2024, Volume and Issue: 16(28), P. 13230 - 13246

Published: Jan. 1, 2024

Nanoarchitectonics may be highly compatible with applications in biological systems. Construction strategies and functions of bio-gel nanoarchitectonics medical tissue engineering are discussed.

Language: Английский

Citations

12

Single-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori DOI Creative Commons
Nianshuang Li, Sihai Chen, Xinbo Xu

et al.

Journal of Advanced Research, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Helicobacter pylori (H. pylori) infection is the main risk for gastric cancer (GC). However, cellular heterogeneity and underlying molecular mechanisms in H. pylori-driven tumorigenesis are poorly understood.

Language: Английский

Citations

12

Anti-stromal nanotherapeutics for hepatocellular carcinoma DOI
Zhuo Yu, Leaf Huang, Jianfeng Guo

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 367, P. 500 - 514

Published: Feb. 3, 2024

Language: Английский

Citations

11